Concourse Financial Group Securities, Inc. Acorda Therapeutics Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share
Q1 2023 May 15, 2023	BUY	$0.55 - $1.0 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.52 - $0.77 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.29 - $0.53 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.3 - $1.67 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.61 - $2.5 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$2.3 - $4.71 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$3.36 - $4.79 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.23 $0 - $0
Q1 2021 May 13, 2021	BUY	$3.8 - $8.04 $0 - $0

Others Institutions Holding ACOR

# of Institutions

Shares Held

133K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

133K
Shares

$34,450
0.16% of portfolio

View Full List

About ACORDA THERAPEUTICS INC

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

More about ACOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account